S-Space

Browse

Author

Showing results 1 to 3 of 3

Issue Date	Title / Author(s) / Citation	File
2015-11	Randomized, double-blind phase II trial with prospective classification by ATM protein level to evaluate the efficacy and tolerability of olaparib plus paclitaxel in patients with recurrent or metastatic gastric cancer Bang, Yung-Jue; Im, Seock-Ah; Lee, Keun-Wook; Cho, Jae Yong; Song, Eun-Kee; Lee, Kyung Hee; Kim, Yeul Hong; Park, Joon Oh; Chun, Hoo Geun; Zang, Dae Young; Fielding, Anitra; Rowbottom, Jacqui; Hodgson, Darren; O'Connor, Mark J.; Yin, Xiaolu; Kim, Woo Ho Journal of Clinical Oncology, Vol.33 No.33, pp.3858-3865	DOI
2023-05	OlympiAD extended follow-up for overall survival and safety: Olaparib versus chemotherapy treatment of physician?s choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer Robson, Mark E.; Im, Seock-Ah; Senkus, Elzbieta; Xu, Binghe; Domchek, Susan M.; Masuda, Norikazu; Delaloge, Suzette; Tung, Nadine; Armstrong, Anne; Dymond, Mike; Fielding, Anitra; Allen, Allison; Conte, Pierfranco European Journal of Cancer, Vol.184, pp.39-47	DOI
2023-08	Olaparib efficacy in patients with germline BRCA-mutated, HER2-negative metastatic breast cancer: Subgroup analyses from the phase III OlympiAD trial Senkus, Elzbieta; Delaloge, Suzette; Domchek, Susan M.; Conte, Pierfranco; Im, Seock-Ah; Xu, Binghe; Armstrong, Anne; Masuda, Norikazu; Fielding, Anitra; Robson, Mark; Tung, Nadine International Journal of Cancer, Vol.153 No.4, pp.1-12	DOI